EnPlusOne is on a mission to bring RNA and RNA solutions to the world. Its ezRNA™ synthesis platform is a stepwise innovation that can incorporate a diverse array of nucleotide modifications and promises a manufacturing process that can sustainably deliver therapeutic RNA at commercial scales. In addition to direct RNA synthesis, EnPlusOne's ezRNA™ platform supports a vast array of RNA solution applications. For more information, please visit www.enplusonebio.com
Company Details
- Employees
- 27
- Address
- 313 Pleasant St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.enplusonebio.com
- Keywords
- Manager jobs.
- HQ
- Watertown, Massachusetts
Enplusone Biosciences Questions
Enplusone Biosciences's website is http://www.enplusonebio.com
Enplusone Biosciences's LinkedIn profile is https://www.linkedin.com/company/enplusone-bio
Enplusone Biosciences has
27 employees.
View email and phone details for 27
employees at Enplusone Biosciences.
Enplusone Biosciences's industry is
Biotechnology Research
Enplusone Biosciences's top competitors are
Nuvation Bio,
Subsense Inc.,
Dispersa,
Garuda Therapeutics,
Wyss Institute At Harvard University,
Variational Ai,
Aadi Bioscience, Inc,
Latent Labs,
Sera Prognostics,
Abcuro, Inc.
Enplusone Biosciences's categories are Biotechnology Research
